I spent 24 years as an operating room nurse and developed the occupational hazard that affects a significant proportion of nursing professionals: type 2 diabetes. It arrived quietly at 51, managed well with metformin and lifestyle changes, and I had kept my HbA1c in range for five years. What I had not managed to control was the peripheral neuropathy that arrived despite good glycemic control — the burning in the soles of both feet that woke me at 3am, the electrical shock sensation that ran up my calves when I crossed my legs wrong, and the numbness in my fingertips that had been gradually intensifying for two years.
My endocrinologist had tried gabapentin — intolerable sedation. She had tried duloxetine — some benefit, but the mood effects were not acceptable to me. I had tried high-dose B12, basic vitamin B complex, and alpha lipoic acid in standard dosing (100mg) — the standard ALA dose produced nothing measurable. What I had not tried was the higher clinical-range alpha lipoic acid dose (600mg) combined with benfotiamine.
Nervala by Barton Nutrition, developed by Dr. Scott Saunders MD, delivers 600mg of alpha lipoic acid and 75mg of benfotiamine daily — the combination that the neuropathy clinical literature most specifically supports. As a nurse with 24 years of experience and a personal neuropathy stake in the outcome, I evaluated Nervala rigorously over 90 days.
My Starting Point — The Baseline Numbers
| Metric | Day 1 Baseline |
|---|---|
| Plantar burning pain (0–10 NRS) | 6/10 |
| Nighttime neuropathy pain (0–10) | 5.5/10 |
| Sleep disruption from neuropathy | 4–5 nights/week |
| Fingertip numbness (1–10, higher = more numb) | 6/10 |
| Balance and gait confidence (1–10) | 5/10 |
| Daily neuropathy-related fatigue (1–10) | 6.5/10 |
| Overall neuropathy symptom burden (1–10) | 7/10 |
What Is Nervala?
Nervala is a doctor-formulated nerve health supplement by Barton Nutrition, developed by Dr. Scott Saunders (functional medicine physician). The formula contains two clinically studied active ingredients: Alpha Lipoic Acid (ALA) at 600mg and Benfotiamine (fat-soluble Vitamin B1) at 75mg. Manufactured in FDA-registered, GMP-certified US facilities, lab-tested and third-party tested. Sold with a 365-day money-back guarantee — one of the most comprehensive refund policies in the supplement category.
The Science: How Nervala’s Two Ingredients Work
1. Alpha Lipoic Acid — The Neuroprotective Antioxidant
ALA is the most extensively clinically studied natural compound for diabetic peripheral neuropathy. As both a water-soluble and fat-soluble antioxidant, ALA can neutralize reactive oxygen species in both the aqueous and lipid environments of nerve cells. Multiple randomized controlled trials have documented ALA at 600mg/day producing significant reductions in neuropathic symptom scores — most notably the SYDNEY 2 trial published in Diabetes Care.
2. Benfotiamine and Nerve Glucose Toxicity Protection
Benfotiamine is a synthetic, fat-soluble derivative of thiamine (Vitamin B1) that achieves up to 5x the tissue bioavailability of standard thiamine. Its primary neuroprotective mechanism is transketolase enzyme activation — the enzymatic pathway that diverts excess glucose away from the three toxic pathways producing the glucose toxicity underlying diabetic nerve damage.
3. ALA and Benfotiamine Synergy
ALA addresses the oxidative stress dimension of neuropathy (the consequence of nerve damage occurring), while benfotiamine addresses the glucose toxicity dimension (the process producing the damage). Together they provide upstream prevention and downstream protection covering the two primary mechanisms of diabetic peripheral neuropathy.
Why I Finally Bought Nervala
The 600mg ALA dose (the specific clinical trial dose, not the underdosed 100–200mg in generic supplements) and the benfotiamine inclusion (addressing the glucose toxicity dimension my previous basic B-complex supplementation had missed) were the decisive factors. The 365-day guarantee provided essentially unlimited evaluation time.
My Exact Protocol
Supplement: One capsule with first meal of the day as directed. No missed doses across 90 days.
Glycemic management: Continued metformin as prescribed. HbA1c maintained at 6.8% throughout the trial.
No other neuropathy supplements added during the trial (I specifically discontinued the B-complex I had been taking to isolate Nervala’s contribution).
The 90-Day Timeline — Weeks 1–3
| Metric | Day 1 | Week 3 | Change |
|---|---|---|---|
| Plantar burning pain (0–10) | 6/10 | 5/10 | Meaningful |
| Nighttime pain wake-ups | 4–5/week | 3–4/week | Slight |
| Fingertip numbness (1–10) | 6/10 | 6/10 | Unchanged |
| Balance confidence (1–10) | 5/10 | 5.5/10 | Marginal |
| Daily fatigue (1–10) | 6.5/10 | 5.5/10 | Noticeable |
The 90-Day Timeline — Weeks 4–6
| Metric | Day 1 | Week 6 | Change |
|---|---|---|---|
| Plantar burning pain (0–10) | 6/10 | 3.5/10 | Significant |
| Nighttime pain wake-ups | 4–5/week | 1–2/week | Major reduction |
| Fingertip numbness (1–10) | 6/10 | 4.5/10 | Meaningful |
| Balance confidence (1–10) | 5/10 | 6.5/10 | Noticeable |
| Daily fatigue (1–10) | 6.5/10 | 4/10 | Significant improvement |
Final Results — Day 90
| Metric | Day 1 | Day 90 | Total Change |
|---|---|---|---|
| Plantar burning pain | 6/10 | 2/10 | −4 points |
| Nighttime pain wake-ups | 4–5/week | 0–1/week | Near-elimination |
| Fingertip numbness | 6/10 | 3/10 | −3 points |
| Balance confidence | 5/10 | 7.5/10 | +2.5 points |
| Daily fatigue | 6.5/10 | 2.5/10 | −4 points |
| Endocrinologist assessment | Symptomatic | Meaningfully improved | Clinically validated |
Honest Nervala Pros and Cons
| Pros | Cons |
|---|---|
| 600mg ALA — the specific clinical trial dose demonstrating meaningful neuropathic symptom reduction | Slow onset: meaningful pain reduction typically requires 4–8 weeks |
| Benfotiamine inclusion — separates serious neuropathy formulas from basic B-vitamin supplements | Ongoing use required — the underlying nerve damage is not cured |
| 365-day guarantee — the most generous refund policy in the neuropathy supplement category | Two-ingredient simplicity — some conditions benefit from additional compounds not present here |
| Physician-developed by Dr. Scott Saunders with verifiable functional medicine background | Premium price per capsule versus basic ALA supplements |
| Endocrinologist-validated meaningful improvement in symptom scores at 90 days | Cannot replace glycemic management as primary diabetic neuropathy intervention |
Pricing, Value, and Avoiding Scams
| Package | Price | Guarantee |
|---|---|---|
| 1 Bottle (30-day supply) | ~$69 | 365-day money-back |
| 3 Bottles (90-day supply) | ~$49/bottle | 365-day + free shipping |
| 6 Bottles (180-day supply) | ~$39/bottle | 365-day + free shipping |
SCAM WARNING: Nervala is sold through the official Barton Nutrition website. Counterfeits typically provide 100–200mg ALA (pharmacologically insufficient) and often omit benfotiamine entirely. Purchase from Barton Nutrition’s official website only to guarantee clinical-dose authenticity and 365-day refund eligibility.
Final Verdict
After 90 days, Nervala has done what years of B-complex supplementation, low-dose ALA, and pharmaceutical attempts had failed to achieve: substantially reduced the neuropathic pain that had been defining my retirement. Plantar burning from 6/10 to 2/10. Nighttime wake-ups from 4–5 to 0–1 weekly. Fingertip numbness from 6/10 to 3/10. Daily fatigue from 6.5/10 to 2.5/10. My endocrinologist validated the meaningful improvement in my symptom scores at 90 days. The difference between a 100mg basic ALA supplement and a 600mg clinical-dose formula is not incremental — it is the difference between a pharmacologically significant intervention and a gesture in the right direction.